Periodontitis is a chronic inflammatory disease that compromises the integrity of the tooth-supporting tissues, which include the gingiva, periodontal ligament and alveolar bone, and are collectively known as the periodontium 1
. Known since antiquity, perio dontitis became prevalent after the domestication of plants and animals in Neolithic societies (~10,000 years ago) when the oral microbiota underwent a distinct compositional shiftwith an increase in the frequency of Porphyromonas gingivalis and other periodontitis-associated speciescompared with earlier hunter-gatherer societies 2 . In its severe form, which afflicts 8.5% of adults in the United States 3 , periodontitis may not only cause tooth loss, but can also affect systemic health by increasing the patients' risk for athero sclerosis, adverse pregnancy outcomes, rheumatoid arthritis, aspiration pneumonia and cancer [4] [5] [6] [7] [8] [9] . A triad of oral anaerobic bacteria that comprises P. gingivalis, Treponema denticola and Tannerella forsythia have traditionally been considered as causative agents of periodontitis, based on their virulence properties and strong association with diseased sites 10 . However, recent data from metagenomic, metatranscriptomic and mechanistic studies [11] [12] [13] [14] [15] [16] are consistent with a new model of periodontal disease patho genesis, which suggests that a more diverse periodontitisassociated microbiota is involved in the disease than previously thought. In this model, disease results not from individual pathogens but rather from polymicrobial synergy and dysbiosis, which perturb the ecologically balanced biofilm associated with periodontal tissue homeostasis [17] [18] [19] (FIG. 1) . The dysbiosis of the periodontal microbiota is characterized by an imbalance in the relative abundance or influence of microbial species that have distinct roles which synergize to shape a pathogenic entity that can cause disease in the oral or extra-oral tissues of susceptible individuals 6, 8, 11, 20 .
In this new model of pathogenesis, the roles of individual bacteria and their interactions with the host need to be re-evaluated.
Central to the new model of the pathogenesis of periodontal disease, and constituting the main theme of this Review, is the active bacterial subversion of the host immune response in ways that enable the persistence of pathogens in the local inflammatory environment of periodontitis and the induction of pathology or complications at systemic sites. We discuss evidence regarding the mechanisms by which periodontal microorganisms disseminate from their oral habitat to distant sites -including atherosclerotic plaques, the lungs and the placenta -where they can disrupt immune surveillance and homeostasis to promote or accelerate pathogenic processes 9, [21] [22] [23] [24] [25] [26] [27] [28] [29] . Moreover, P. gingivalis in particular is examined as a potential cause for the generation of autoantibodies in rheumatoid arthritis 5, [30] [31] [32] [33] . Understanding how oral pathogens misdirect the host immune response can provide novel mechanistic insights into the pathogenesis of periodontitis and associated systemic conditions, as well as reveal new therapeutic targets.
Microbial synergy and dysbiosis
The transition from periodontal health to disease is associated with a dramatic shift from a symbiotic microbial community -which is composed mostly of facultative bacterial genera such as Actinomyces and Streptococci -to a dysbiotic microbial community that is mainly composed of anaerobic genera from the phyla Firmicutes, Proteobacteria, Spirochaetes, Bacteroidetes and Synergistetes. The dysbiotic oral microbiota is enriched in virulence factors and has adapted to thrive in an inflammatory environment [11] [12] [13] [14] 34 . The predominant habitat of periodontitis-associated bacteria is the subgingival crevice, where the bacteria are found in Dysbiosis A condition that is characterized by an imbalance in the relative abundance or influence of species within a microbial community that is associated with a disease; for instance, periodontitis or inflammatory bowel disease.
Homeostasis
A condition of equilibrium or stability in a system that is maintained by adjusting physiological processes to counteract external changes. An example of homeostasis is the balanced relationship between host tissues and the resident microbiota that prevents destructive inflammation or disease.
Pathobionts
Commensal microorganisms with the potential to induce pathology under conditions of disrupted homeostasis.
distinct microenvironments -the tooth-associated biofilm, the gingival crevicular fluid and the epithelium lining the crevice 19 (FIG. 1a) . The subgingival environment is rich in immune and inflammatory mediators, and provides unique challenges and opportunities for the bacteria [35] [36] [37] . Periodontal health requires a controlled immuno-inflammatory state that can maintain host-microorganism homeostasis in the periodontium 38 . However, in periodontitis, the host immune response is dysregulated -either because it is subverted by the microbial community or because of host immuno regulatory defects -and is therefore ineffective at restraining bacterial outgrowth and overt pathogenicity 19 . A poorly controlled host immune response can, in turn, generate a self-perpetuating pathogenic cycle, in which dysbiosis and inflammation reinforce each other by forming a positive feedback loop (FIG. 1b) .
Most studies investigating microbial subversion of the periodontal host immune response have primarily used P. gingivalis as a model pathogen and therefore this patho gen is the focus of this Review. Decades of research have identified a plethora of documented or putative virulence factors of P. gingivalis that may contribute to its persistence in the subgingival region (reviewed in REFS 37, 39) . However, it is only now that we have begun to understand how this Gram-negative, asaccharo lytic bacterium integrates its virulence attributes to enhance the pathogenicity of a polymicrobial community. Although P. gingivalis was thought to be capable of directly causing periodontitis in animal models 40 , it is now established that P. gingivalis-induced periodontitis requires the presence of the commensal microbiota, as P. gingivalis is unable to cause periodontitis in germ-free mice despite colonizing this host 15 . In this context, P. gingivalisalthough only present at a low frequency -is pathogenic owing to its ability to induce dysbiotic microbial communities and thereby act as a keystone pathogen 16, 41 . Manipulation of the host immune response is fundamental to the capacity of P. gingivalis to instigate quantitative and qualitative alterations in the oral microbiota, which can thereby trigger inflammatory periodontal bone loss that is largely mediated by pathobionts [42] [43] [44] . Although nonpathogenic by themselves in the oral environment, certain commensals such as Streptococcus gordonii promote P. gingivalis colonization and, as such, are implicated as accessory pathogens 19, 45 . It should be noted that the presence of P. gingivalis does not necessarily precipitate disease. Indeed, P. gingivalis is detectable, albeit at a decreased frequency, in periodontally healthy individuals 11, 46 . This might be explained by the considerable strain diversity within the population of P. gingivalis. Moreover, key virulence factors of this pathogen (such as gingipains and lipid A phosphatases) are regulated by local environmental conditions, which may differ among individuals 41 . In a related context, there might be individuals who can resist the conversion of a symbiotic microbiota into a dys biotic one by virtue of their intrinsic immune status, for example, owing to alterations in the signalling pathways that are required for immune subversion by P. gingivalis or other keystone-like pathogens.
The concept that P. gingivalis cooperates with other periodontal microorganisms is supported by findings in animal models of periodontitis in which combined inoculation of P. gingivalis with accessory pathogens or other keystone-like pathogens, such as S. gordonii or T. forsythia, respectively, leads to enhanced alveolar bone loss compared with inoculation of P. gingivalis alone [47] [48] [49] [50] . This synergism may not be restricted to manipulation of the host response, but may also entail cooperative interspecies communication that further promotes bacterial fitness and hence dysbiosis. At least in vitro, communication among periodontal bacteria causes reciprocal transcriptomic and proteomic responses that regulate nutrient acquisition, metabolic processes and the production of virulence factors [51] [52] [53] . In summary, the emerging polymicrobial synergy and dysbiosis model suggests that the host immune response is initially subverted by keystone pathogens that are aided by accessory pathogens, and is subsequently overactivated by pathobionts, thereby linking the breakdown of homeostasis with destructive inflammation in susceptible individuals (FIG. 1b) . Specific molecular mechanisms by which periodontal bacteria manipulate the host response to cause dysbiotic inflammation are discussed below.
Subversion of host immune responses
The dysbiotic periodontal community is faced with a survival conundrum: on the one hand, these bacteria need to evade immune-mediated killing; on the other hand, they require inflammation to procure nutrients from tissue breakdown (such as degraded collagen peptides and haem-containing compounds) 20 . Hence,
Box 1 | Periodontitis and susceptibility factors
Periodontitis has a complex aetiology that acts at multiple levels: at the microbial level, based on the presence of dysbiotic microbial communities with potential for destructive inflammation; at the host level, based on genetic factors that may predispose to or protect from disease; and at the level of systemic health status and environmental factors that modify the host response in either a protective direction or a destructive direction 151 . Accordingly, dysbiosis alone may not necessarily precipitate periodontitis, but it could initiate disease in the context of other risk factors, such as host genotype, stress, diet or behaviour (for example, smoking) 92, [152] [153] [154] [155] [156] . For instance, there might be individuals who can tolerate dysbiosis by virtue of their intrinsic immuno-inflammatory status; hyporesponsive or lack-of-function polymorphisms in immune response genes could attenuate inflammation and prevent the development of overt disease 20 . Bacterial dysbiosis will only lead to disease in susceptible hosts as there are individuals who remain periodontally healthy despite massive tooth-associated biofilm formation, whereas others with less biofilm accumulation are extremely susceptible to periodontitis 154 . Although a genetic basis for periodontitis is supported by twin studies and familial aggregation of severe forms of the disease, there is debate concerning the role of specific genes, such as IL1B (which encodes interleukin-1β (IL-1β)), IL6 (which encodes IL-6), TNF (which encodes tumour necrosis factor), FCGR2A (which encodes Fcγ receptor IIA), C5 (which encodes complement component C5), CD14 and WNT5A [153] [154] [155] . This uncertainty is probably attributable to the fact that chronic periodontitis is a polygenic disease, in which multiple genes contribute cumulatively to the overall disease risk (or protection) by influencing the host immune response and the composition and structure of the microbiota 155 . This notion stands in stark contrast to monogenic forms of the disease, such as aggressive periodontitis in young patients with leukocyte adhesion deficiency, in which a single gene (ITGB2; which encodes integrin β2) invariably precipitates periodontal disease 57 .
Accessory pathogens
Commensal bacteria that are not pathogenic by themselves in a given niche, but that can enhance the virulence of keystone pathogens by, for example, facilitating their colonization or providing metabolic support.
Gingipains
A family of trypsin-like cysteine proteinases that are secreted by P. gingivalis and contribute to its virulence, as well as to the pathogenesis of periodontitis. Members of this family include the high molecular mass arginine-specific gingipain A (HRgpA), the arginine-specific gingipain B (RgpB) and the lysine-specific gingipain (Kgp).
Inflammophilic
This term refers to bacteria that thrive on inflammation as they feed off inflammatory tissue breakdown products. The literal meaning is 'attracted to inflammation', which is derived from the combined meaning of inflammation and the Greek suffix philic denoting fondness.
Periodontal pockets
The pathologically deepened subgingival crevices in periodontitis, which are characteristic of the disease.
immunosuppression, although a common evasion strategy used by many pathogens 54 , is not a viable option for inflammophilic bacteria 55 . Periodontal bacteria can manipulate their interactions with host immune responses -such as neutrophils and complement -to enhance bacterial fitness.
The role of neutrophils in periodontitis. Neutrophils are the most common leukocyte recruited to the subgingival crevice or periodontal pockets 35, 36 . Individuals with congenital deficiencies in neutrophil numbers or recruitment develop severe periodontitis, suggesting that neutrophils are required for periodontal tissue homeostasis 17, 56, 57 . 10 bacteria that feed on inflammatory spoils such as collagen peptides and haem-containing compounds, which are carried with the gingival crevicular fluid (GCF) that bathes the pocket. b | Periodontitis is induced in susceptible hosts by a polymicrobial community, in which different members have distinct roles that converge synergistically to cause destructive inflammation. Keystone pathogens -the colonization of which is facilitated by accessory pathogens -initially subvert the host response leading to a dysbiotic microbiota, in which pathobionts overactivate the inflammatory response and cause periodontal tissue destruction, including resorption of the supporting alveolar bone. Inflammation and dysbiosis positively reinforce each other because inflammatory tissue breakdown products are used as nutrients by the dysbiotic microbiota. TLR, Toll-like receptor. However, hyperactive, supernumerary or dysregulated neutrophils can cause collateral tissue damage through the release of inflammatory and toxic substances or tissue-degrading enzymes 35, [58] [59] [60] . Indeed, ample clinical evidence shows that neutrophils mediate a significant amount of periodontal tissue destruction 61, 62 and that their local numbers positively correlate with the severity of chronic periodontitis 63 . The chronic recruitment of excessive numbers of neutrophils to diseased periodontal pockets possibly arises from their inability to control the microbial challenge, despite being viable and capable of eliciting immune responses 20, 58 . This suggests that the microorganisms can evade neutrophil-mediated killing while promoting inflammation, thereby contributing to dysbiosis. Indeed, as discussed below, periodontal bacteria can subvert complement function in ways that interfere with neutrophil-mediated killing in a persisting inflammatory environment 42 .
Complement subversion.
Complement is a cascade system involving a network of proteins and receptors that are crucially involved in immunity and inflammation 64 . Complement activation is initiated by distinct mechanisms, which converge at the third complement component (C3) and lead to the generation of effector molecules. These effector molecules mediate microbial opsonization and phagocytosis (for example, the opsonin C3b interacts with complement receptor 1); recruitment and activation of inflammatory cells (such as anaphylatoxin C5a, which interacts with the C5a receptor (C5aR)); and direct lysis of targeted microorganisms (mediated by the C5b-C9 membrane attack complex) 64 . P. gingivalis, T. forsythia and Prevotella intermedia can protect themselves and 'bystander' bacteria from human complement-mediated opsonophagocytosis and killing by blocking complement activation through the degradation of C3 or of key upstream components, such as the mannose-binding lectin [65] [66] [67] . Importantly, the bacterial proteases involvednamely, gingipains, karilysin and interpain A (which are expressed by P. gingivalis, T. forsythia and P. intermedia, respectively) -act synergistically to inhibit complement, which may lead to enhanced protection of complementsusceptible bystander species [65] [66] [67] . P. intermedia and T. denticola can also evade human complement-mediated killing by capturing complement factor H, which is a physiological inhibitor of complement 68, 69 . Intriguingly, the arginine-specific gingipains of P. gingivalis can cleave C5 to generate high local concentrations of C5a independently of canonical complement activation 65, 70 . Hence, in neutrophils, which recognize P. gingivalis through Toll-like receptor 2 (TLR2) 71 , this pathogen can coactivate C5aR and TLR2, which in turn leads to signalling crosstalk 42 . In both human and mouse neutrophils, this C5aR-TLR2 crosstalk leads to ubiquitylation and proteasomal degradation of myeloid differentiation primary response protein 88 (MYD88), a TLR2 signalling adaptor, and thereby suppresses its antimicrobial effects 42 ( FIG. 2) . Moreover, the C5aR-TLR2 crosstalk activates an alternative pathway in which the TLR2 adaptor MYD88 adaptor-like protein (MAL; also known as TIRAP) induces phosphoinositide 3-kinase (PI3K) signalling, which in turn inhibits RHOA GTPase-dependent actin polymerization, and hence the phagocytosis of P. gingivalis and bystander bacteria 42 . The PI3K pathway also stimulates a robust inflammatory response 42 (FIG. 2) . Importantly, the local inhibition of C5aR, TLR2 or PI3K in the periodontium of P. gingivalis-colonized mice leads to the elimination of P. gingivalis, reverses the increase in total microbiota numbers that are induced by P. gingivalis colonization and blocks periodontal inflammation 42 . In summary, P. gingivalis manipulates neutrophils through distinct mechanisms that together ensure the survival of the microbial community and the perpetuation of inflammation.
Interestingly, the karilysin of T. forsythia was recently shown to also cleave C5 to release C5a 66 . As T. forsythia activates TLR2 (REF. 72 ), it is important to determine whether this bacterium can instigate subversive crosstalk between C5aR and TLR2 similar to that of P. gingivalis, or whether the two microorganisms can synergize in that regard. Intriguingly, both gingipains and karilysin readily degrade the C5b component of C5, and thereby prevent the formation of the membrane attack complex 65, 66 .
Additional immune-subversive mechanisms. Major immune-subversive microorganisms probably use additional strategies to protect bystander bacteria and elevate the virulence of the entire microbial community, although most of these putative mechanisms have not been confirmed in vivo. For instance, the capacity of P. gingivalis to degrade and inactivate antimicrobial peptides might confer in vivo protection to bystander bacteria 36, 67 . In a related context, T. denticola blocks the production of human β-defensins by gingival epithelial cells in response to Fusobacterium nucleatum, a microorganism that promotes the colonization of periodontitisassociated bacteria 73 . Mechanistically, T. denticola blocks the fusion of internalized F. nucleatum with lysosomes and suppresses the induction of intracellular reactive oxygen species, thereby inhibiting TLR responses that control human β-defensin expression 73 . Macrophages can engulf periodontal bacteria that invade the gingival connective tissue. However, P. gingivalis can induce cyclic AMP-dependent activation of protein kinase A, which inhibits the expression of inducible nitric oxide synthase, thereby suppressing nitric oxide-dependent intracellular killing in macrophages 74 . Moreover, P. gingivalis suppresses human and mouse macrophage endocytosis of F. nucleatum, an event that is required for NOD-, LRRand pyrin domain-containing 3 (NLRP3) inflammasome activation in response to this bacterium 75 . This mechanism may promote the fitness of the periodontal community as inflammasome activation induces pyroptosis -a pro-inflammatory mode of lytic cell death -protecting the host against infection 76 . P. gingivalis is also thought to manipulate adaptive immune responses by favouring the differentiation and recruitment of CD4 + T helper 17 (T H 17) cells at the expense of the T H 1 lineage [77] [78] [79] . Although it has been argued that T H 17 cells contribute to destructive periodontal inflammation, whereas T H 1 cells are involved in protective cell-mediated immunity 80, 81 , more research is warranted to elucidate the roles of the various T cell subsets in the pathogenesis of periodontal disease.
When the periodontium is chronically exposed to a dysbiotic microbial community -which apparently evolved to evade the host immune response, while promoting its inflammatory aspects -it probably has an adverse impact on systemic health. Below, we examine the established and emerging mechanisms by which perio dontal bacteria can subvert host signalling pathways to instigate chronic inflammation in extra-oral sites.
Periodontitis and cardiovascular disease
Numerous cross-sectional, case-control and cohort epidemiological studies suggest that periodontitis is associated with atherosclerotic cardiovascular disease, independently of confounding factors such as smoking and obesity 6, 82, 83 . Moreover, clinical interventional studies indicate that the treatment of periodontitis reduces systemic inflammation and has favourable effects on subclinical markers of atherosclerosis, including improved endothelial function (as determined by flowmediated dilatation) [83] [84] [85] . Moreover, a recent study has shown that longitudinal improvement in periodontal health is related to decreased progression of carotid atherosclerosis in humans 86 .
At least two biologically plausible mechanisms may account for a causative link between periodontitis and atherosclerosis 4, 83 (FIG. 3) . First, gingival ulceration in periodontal pockets (FIG. 1a) enables the translocation of bacteria into the systemic circulation, causing bacteraemia that is well documented in patients with periodontitis and that may provide an atherogenic stimulus 4, 83 . This notion is supported by findings showing that recurrent experimental bacteraemia (using P. gingivalis as a model pathogen) promotes coronary and aortic atherogenesis in pigs with or without hypercholesterolaemia 87 . Additionally, in a subset of patients with severe periodontitis and an ulcerated gingival epithelium, locally produced pro-inflammatory cytokines -such as tumour necrosis factor (TNF), interleukin-1β (IL-1β) and IL-6 -can enter the systemic circulation and induce an acute-phase response in the liver (including elevated levels of C-reactive protein, fibrinogen and serum amyloid A) and thereby promote atherogenesis 4, 88 . In support of this mechanism, patients with severe periodontitis have increased systemic inflammation -as indicated by elevated levels of cytokines and acutephase markers, such as IL-6 and C-reactive protein, convertase-like activity (high molecular mass arginine-specific gingipain A (HRgpA) and arginine-specific gingipain B (RgpB)) that generate high local concentrations of C5a ligand. P. gingivalis can co-activate complement C5a receptor (C5aR) and TLR2 in neutrophils, and the resulting crosstalk leads to the ubiquitylation and proteasomal degradation of the TLR2 adaptor myeloid differentiation primary response protein 88 (MYD88), thereby inhibiting a host-protective antimicrobial response. This proteolytic event requires the C5aR-TLR2-dependent release of transforming growth factor β1 (TGFβ1), which mediates MYD88 ubiquitylation via the E3 ubiquitin-protein ligase SMURF1 (enlarged inset). Moreover, the C5aR-TLR2 crosstalk activates phosphoinositide 3-kinase (PI3K), which prevents phagocytosis through the inhibition of RHOA GTPase and actin polymerization, while stimulating the production of inflammatory cytokines. In contrast to MYD88, another TLR2 adaptor, MYD88-like adaptor protein (MAL), contributes to immune subversion by acting upstream of PI3K. These functionally integrated pathways, as manipulated by P. gingivalis, provide 'bystander' protection to otherwise susceptible bacterial species and promote polymicrobial dysbiotic inflammation in vivo. respectively -compared with healthy controls, whereas treatment of periodontitis reduces systemic inflammation in patients with or without a history of cardio vascular disease 83, 85 . An alternative mechanism was suggested by a recent study in mice, which showed that P. gingivalis can cause alterations to the gut microbiota, leading to indirect induction of systemic inflammation 89 (FIG. 3) . Specifically, mice that were orally infected with P. gingivalis showed an increased proportion of Bacteroidetes and a decreased proportion of Firmicutes within their gut microbiota relative to sham-infected controls, which correlated with the decreased expression of tight-junction proteins in the ileum, and with the development of endotoxaemia and systemic inflammation. Although large quantities of oral bacteria are constantly swallowed via the saliva in humans and animals, P. gingivalis was not detected in the gut of infected mice; therefore, the mechanism by which it causes compositional changes to the gut microbiota remains uncertain. The mechanistic basis of the association between periodontitis and atherosclerosis is substantiated by studies in animal models that were based on oral infection with P. gingivalis, which has been detected in human atherosclerotic tissue, and by clinical or in vitro studies attesting to the atherogenic potential of periodontal bacteria 6, [25] [26] [27] [28] [29] [90] [91] [92] [93] [94] .
Animal model-based evidence. Oral infection with P. gingivalis of rabbits fed a high-fat diet, or of atherosclerosisprone (hyperlipidaemic) apolipoprotein E-deficient (ApoE −/− ) mice on a standard chow diet, causes not only local bone loss, but also systemic inflammation and athero sclerotic lesions 28, 90, 91 . The ApoE −/− mouse model of combined periodontitis and atherosclerosis has been extensively used and has provided insights into the role of TLR signalling in the disease process. Whereas TLR2 has an important role in mediating P. gingivalis-induced inflammatory atherosclerosis 95 , the disease phenotype requires P. gingivalis to evade TLR4-mediated detection 29 .
In this regard, P. gingivalis can enzymatically modify the lipid A moiety of its lipopolysaccharide to either evade or antagonize TLR4 activation in macrophages 17 .
The shifting of lipid A activity from TLR4-evasive to Nature Reviews | Immunology In periodontitis, locally produced pro-inflammatory cytokines can enter the systemic circulation and induce an acute-phase response in the liver -which is characterized by increased levels of C-reactive protein (CRP), fibrinogen and serum amyloid A -and in turn contribute to atherosclerosis or intra-uterine inflammation. Moreover, gingival ulceration in periodontal pockets enables the egress and systemic dissemination of periodontal bacteria. Certain bacteria, including Porphyromonas gingivalis, have been detected in circulating leukocytes and in atherosclerotic lesions, where they may act as pro-atherogenic stimuli. Other periodontal bacteria, such as Fusobacterium nucleatum, have been detected in the placenta where they can cause adverse pregnancy outcomes. Large quantities of oral bacteria are constantly swallowed via the saliva into the gut. In this context, an alternative or additional mechanism that links periodontitis to systemic inflammation was recently proposed; swallowed P. gingivalis may cause alterations to the gut microbiota, thereby leading to increased gut epithelial permeability and endotoxaemia, which causes systemic inflammation. Although independent, the depicted events are not mutually exclusive and could, in principle, occur simultaneously. The blue circles in the fetal-placental compartment indicate bacterial invasion and the white circles indicate the dissemination of inflammatory mediators. IL, interleukin; TNF, tumour necrosis factor.
Non-canonical inflammasome
A caspase-11-dependent pathway of inflammasome activation that is crucial for the control of infections caused by Gram-negative bacteria and can induce cell death (pyroptosis) independently of caspase 1.
Atheromas
Accumulated fatty deposits in the inner lining (intima) of an artery that lead to the restriction of blood flow and an increased risk of thrombosis.
TLR4-antagonistic depends on endogenous lipid A phosphatase activity 96 , which is regulated by the growth phase or by environmental factors including temperature and haemin availability 97, 98 . Differential activities of lipid A 1ʹ-and 4ʹ-phosphatases are associated with the synthesis of distinct lipid A structures, comprising nonphosphorylated tetra-acylated lipid A (which is inert for TLR4 activation), monophosphorylated penta-acylated lipid A (which is a weak TLR4 agonist) and monophosphorylated tetra-acylated lipid A (a TLR4 antagonist). Genetic ablation of 4ʹ-phosphatase activity (or bacterial growth at ≥39 °C) leads to the synthesis of TLR4-agonistic lipid A, whereas ablation of 1ʹ-phosphatase activity -or growth in haemin-replete conditions, which are expected to be present in an inflammatory environment -leads to the synthesis of TLR4-antagonistic lipid A 96, 99 . Remarkably, in addition to preventing TLR4 activation, the production of inert or antagonistic lipid A also increases the resistance of P. gingivalis to cationic antimicrobial peptides, owing to changes in the outer surface charge of the bacteria that affect the binding of cationic peptides 29, 96, 97, 99 . Importantly, the TLR4-antagonistic lipid A of P. gingivalis inhibits TLR4 activation in response to other bacteria that express the TLR4-agonistic lipid A species 100, 101 .
In ApoE −/− mice orally infected with wild-type P. gingivalis, or isogenic phosphatase mutants with a 'locked' lipid A profile, the expression of inert or antagonistic lipid A was associated with elevated vascular inflammation, macrophage infiltration and the progression of atherosclerosis 29 . In macrophages infected with the same set of wild-type or mutant strains, the expression of lipid A structures that prevent or block TLR4 activation was associated with evasion of non-canonical inflammasome activation and increased bacterial survival, compared with the expression of TLR4-agonistic lipid A 29 .
Taken together with an earlier study by the same group 95 , these findings suggest that the capacity of P. gingivalis to prevent TLR4 signalling while activating TLR2 leads to atherogenic inflammation at sites distant from the initial infection. Using a similar ApoE −/− model, an independent study confirmed the causal link between periodontitis and atherosclerosis and, moreover, detected P. gingivalis in aortic tissues (including vascular endothelial cells) using fluorescent in situ hybridization 28 .
Immune subversion and atherogenic potential.
Although periodontal bacteria have been identified in atheromas [25] [26] [27] [92] [93] [94] , the mode of their relocation is uncertain and could involve mechanisms alternative or additional to the bacteraemic route. In principle, bacteria might exploit recirculating leukocytes -such as macrophages and/or dendritic cells (DCs) -as 'Trojan horses' for dissemination to systemic tissues. In this regard, the ability of P. gingivalis to survive intracellularly in macrophages 29, 102 and DCs 27 is intriguing. To persist intracellularly in macrophages, P. gingivalis needs to enter the macrophage via complement receptor 3 in cholesterol-rich lipid rafts 102, 103 , which is consistent with observations that pathogens which invade through lipid rafts are not readily directed to late endosomes and lysosomes, where they would be killed 104 .
To survive within DCs, P. gingivalis needs to enter via the C-type lectin DC-specific ICAM3-grabbing non-integrin (DC-SIGN; also known as CD209) 105, 106 (FIG. 4) . Both processes are mediated by the fimbrial proteins of P. gingivalis; FimA fimbriae directly interact with complement receptor 3 on macrophages, whereas Mfa1 fimbriae interact with DC-SIGN on DCs 102, 106 . The exploitation of DCs as transport vehicles for P. gingivalis is supported by a recent clinical study that identified P. gingivalis (using 16S ribosomal DNA sequencing) within blood myeloid DCs from patients with chronic periodontitis 27 . The rate and frequency of DC carriage of P. gingivalis was increased after bacteraemia elicited by debridement, which is a routine clinical procedure that involves the removal of the dental plaque biofilm and calculus from the teeth and gingiva. Moreover, immunofluorescence analysis revealed colocalization of P. gingivalis with myeloid DCs that were infiltrating either the oral mucosa or atherosclerotic plaques of patients with chronic periodontitis 27 . A mechanistic understanding of these clinical observations was provided by in vitro studies showing that P. gingivalis subverts human DC function 27, 105, 106 . Specifically, following binding to DC-SIGN, P. gingivalis not only enters and survives within myeloid DCs, but also promotes an atherogenic phenotype in the cells, as indicated by the upregulation of matrix metalloproteinase 9 and complement C1q proteins, which are indicators of the risk of plaque rupture 27 . Furthermore, P. gingivalis selectively upregulates the expression of CXC-chemokine receptor 4 (CXCR4), but not that of CC-chemokine receptor 7 (CCR7), and thereby disrupts DC migration towards CC-chemokine ligand 19 (CCL19) and promotes migration towards CXCchemokine ligand 12 (CXCL12) 107 . Consistent with this, peripheral blood myeloid DCs from patients with chronic periodontitis are characterized by high expression of CXCR4 and low expression of CCR7 compared with DCs from healthy individuals 107 . CCR7 mediates homing to secondary lymphoid organs, whereas CXCR4 mediates homing to sites of neovascularization, such as atherosclerotic plaques 108, 109 ; therefore, the authors suggested that P. gingivalis hijacks and directs DC migration to inflammatory vascular sites, where the pathogen can exacerbate inflammatory pathology 107 . An alternative transport vehicle for P. gingivalis in the blood might be erythrocytes, which bind to C3b-opsonized P. gingivalis in a complement receptor-1-dependent manner 110 (FIG. 4) . Although leukocytes fail to bind and internalize erythrocyte-attached P. gingivalis, this may not necessarily be an evasion strategy, as erythrocyte-associated bacteria can eventually be cleared by liver macrophages (also known as Kupffer cells). However, because the interaction of P. gingivalis with erythrocytes gradually declines over time -which is attributed to bacterial degradation of bound C3b -resulting in the release of viable bacteria in vitro, the authors speculated that erythrocyte-carried P. gingivalis can potentially infect endothelial cells at extra-oral sites and thereby contribute to vascular inflammation 110 (FIG. 4) . This intriguing hypothesis remains to be tested in animal models.
P. gingivalis can indeed invade human aortic endothelial cells by means of its FimA fimbriae and subsequently suppress the levels of key intracellular molecules that are involved in cell death and host defence (such as NLRP3 and receptor-interacting serine/threonineprotein kinase 1), which leads to a permissive intracellular environment 6, 94, 111, 112 . FimA fimbriae also induce the TLR2-dependent expression of endothelial adhesion molecules (such as intercellular adhesion molecule 1 (ICAM1), vascular cell adhesion molecule 1 (VCAM1) and E-selectin) and chemokines (such as MCP1 (also known as CCL2) and CXCL8 (also known as IL-8)) that are involved in leukocyte recruitment, as well as inside-out TLR2 signalling, which activates leukocyte integrins that mediate transendothelial migration 6, 113, 114 . However, additional TLR2 ligands of P. gingivalis, including serine lipids and lipoproteins 115, 116 , probably also participate in these pro-atherogenic activities. In addition to a bacteraemic route, periodontal bacteria may hijack leukocytes or erythrocytes -to which they attach via a C3b-complement receptor 1 (CR1) interaction -to disseminate from the oral mucosa to aortic tissues. Bacteria not only invade but also activate endothelial cells by upregulating cell adhesion molecules and chemokines, which can promote the transmigration of leukocytes that may harbour viable intracellular bacteria. The bacteria can spread to deeper tissues where they can induce the proliferation of smooth muscle cells (SMCs) in the intima. The uptake of low-density lipoproteins (LDLs) by transmigrated macrophages is enhanced in the presence of bacteria, leading to accelerated foam cell formation and atherogenesis. At later stages, atherosclerotic plaque rupture can be facilitated by the bacteria-induced production of matrix metalloproteinases (MMPs) by lymphocytes or myeloid cells. Bacteria-induced platelet aggregation -occurring either directly or through the induction of prothrombotic autoantibodies -may contribute to thrombotic vessel occlusion. Most of the studies supporting this model used Porphyromonas gingivalis as a model pathogen; the survival of this pathogen within leukocytes depends partly on Toll-like receptor 4 (TLR4) evasion, as well as on its capacity to exploit CR3 in macrophages or DC-specific ICAM3-grabbing non-integrin (DC-SIGN) in dendritic cells (DCs) for safe intracellular entry. 
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Other studies using P. gingivalis as a pro-atherogenic model bacterium have shown that it can accelerate atherothrombosis via the recruitment and activation of neutrophils 117 , and can induce platelet aggregationan activity facilitated by the interactions of P. gingivalis haemagglutinins with the platelet glycoprotein IIb-IIIa (also known as αIIbβ3 integrin) on platelets via a fibrinogen bridge 118 . P. gingivalis may also contribute to cardiovascular disease pathology via molecular mimicry. Specifically, when compared with healthy individuals, a substantial subset of patients with periodontitis have elevated concentrations of cardiolipin-specific antibodies in the gingival crevicular fluid and serum; these are prothrombotic autoantibodies associated with atherosclerosis and also with adverse pregnancy outcomes (see discussion below). Such autoantibodies can be induced in response to bacterial epitopes -such as those found in P. gingivalis arginine-specific gingipains and T. denticola phosphoglycerate kinase -that bear homology to the TLRVYK peptide of the phospholipid-binding serum protein β2-glycoprotein 1 (REFS 119,120). Furthermore, P. gingivalis enhances low-density lipoprotein uptake and foam cell formation by upregulating the expression of CD36 (a scavenger receptor mediating lipid uptake; also known as platelet glycoprotein 4) and downregulating the expression of ABC transporter A family member 1 (which mediates the efflux of cholesterol from macrophages) 121, 122 . In a similar context, the pathogen induces the proliferation of vascular smooth muscle cells, which leads to neointima formation, and stimulates the production of matrix metalloproteinases that contribute to plaque rupture and thrombotic vessel occlusion 6 (FIG. 4) .
In summary, periodontal pathogens evade the immune system to induce atherogenic inflammation, although their impact beyond the oral cavity is not restricted to the cardiovascular system but includes additional tissues (see below).
Periodontitis and adverse pregnancy outcomes
Epidemiological and clinical studies suggest that maternal periodontitis may be associated with an increased risk of adverse pregnancy outcomes such as low birth weight, pre-term birth, miscarriage and/or stillbirth 9, 21, 123 . Similar to atherosclerosis, two major plausible biological mechanisms have been proposed: first, periodontal pathogens that disseminate systemically may cross the placenta into the fetal circulation and amniotic fluid; and second, inflammatory mediators that are produced locally in the periodontium could enter the systemic circulation and stimulate an acutephase response, and thereby adversely affect the placenta and fetus (FIG. 3) . The notion that periodontal bacteria can cause pregnancy complications is supported by mechanistic studies in animal models.
F. nucleatum -a potential accessory pathogen that facilitates the colonization of periodontitis-associated bacteria -becomes an overt pathogen if it translocates to extra-oral sites 8 . Indeed, the bacterium can be isolated from abscesses in several internal organs and it is implicated in adverse pregnancy outcomes and in colorectal cancer
. Clinical studies have linked F. nucleatum to several pregnancy complications, including premature birth, stillbirth and neonatal sepsis 8 . Moreover, the identification of F. nucleatum clones in the subgingival biofilm of a mother with pregnancy-associated gingivitis and her stillborn infant suggests that the bacterium can disseminate from the mother's gingiva to her uterus 21 . Experiments in pregnant mice have provided insights into how F. nucleatum can cause intra-uterine infection and inflammation. Specifically, intravenously administered F. nucleatum (to mimic bacteraemia) uses its E-cadherin-binding FadA adhesin to cross the endothelium and colonize the fetalplacental compartment, where it induces TLR4-dependent necro-inflammatory responses 124 . In contrast to F. nucleatum, Escherichia coli fails to induce fetal loss in the same model 125 . Whereas F. nucleatum can colonize the placenta of TLR4-deficient mice, these mice display substantially decreased fetal death rates compared with wild-type mice, which indicates that fetal loss is caused by inflammation rather than by bacterial colonization per se 124 . Certain other periodontal bacteria, including P. gingivalis, were also shown to colonize the placenta and fetal tissues of mice or rats, thereby causing inflammation and pregnancy complications (reviewed in REF. 9 ). P. gingivalis may also induce adverse pregnancy outcomes through alternative mechanisms. Cardiolipin-specific antibodies are associated with certain disorders, including adverse pregnancy outcomes 119 , and a subset of patients with periodontitis have increased concentrations of such autoantibodies 126 , which could be induced in response to cross-reactive bacterial epitopes such as the argininespecific gingipains of P. gingivalis 119 . The possible connection between P. gingivalis, cardiolipin-specific antibodies and pregnancy complications was strengthened recently. A study showed that antibodies raised against P. gingivalis -but not against an isogenic gingipain-deficient mutant -cause fetal loss when passively administered to pregnant female mice 127 . Importantly, this effect was substantially inhibited when cardiolipin-specific antibodies were removed from the antibody preparations 127 . In summary, pregnancy complications can be caused by periodontal pathogen-induced inflammatory responses, or by autoantibodies, which have also been implicated in the association of periodontitis with rheumatoid arthritis.
P. gingivalis and rheumatoid arthritis
Several studies indicate an epidemiological association between periodontitis and rheumatoid arthritis, even after adjusting for common risk factors such as smoking [128] [129] [130] . In a distinct clinical phenotype of rheumatoid arthritis, anti-citrullinated protein antibodies (ACPAs) act as diagnostic markers as they are detected in the serum before the onset of the disease and their serum levels correlate strongly with disease severity 131 . A recent study showed that patients with rheumatoid arthritisparticularly those with ACPA-positive rheumatoid arthritis -have a higher incidence of periodontitis than control patients with osteoarthritis. Furthermore, in these patients, the detection of P. gingivalis in subgingival biofilm samples was associated with increased levels of ACPAs, irrespective of smoking status 32 . The molecular underpinnings of these associations are discussed below.
Peptidyl-arginine deiminase. P. gingivalis is unique among other periodontal bacteria, and possibly among all bacterial species, with regard to its expression of peptidyl-arginine deiminase (PPAD), which is an enzyme that converts protein arginine residues into citrulline 5, 33 . Protein citrullination has been implicated in several physiological processes 132 ; however, because citrullination can dramatically alter protein structure and function, dysregulated citrullination of host proteins by microbial enzymes could interfere with normal host cell signalling and immune or other homeostatic functions. For instance, P. gingivalis PPAD citrullinates the carboxy-terminal arginine of epidermal growth factor (EGF), thereby inhibiting its biological activity, as shown by impaired EGF-induced fibroblast proliferation and migration 133 . Interestingly, citrullination of two internal arginine residues of EGF by human peptidyl-arginine deiminase (PAD) enzymes does not abrogate EGF function 133 . As EGF has an essential role in wound healing and tissue regeneration, its inactivation by P. gingivalis may interfere with the healing of periodontal tissue and thus delay the resolution of inflammation.
Box 2 | Oral bacteria and cancer
Accumulating evidence indicates that a temporal and spatial association exists between oral bacteria and cancer 7, 157 . Fusobacterium nucleatum is associated with colorectal cancer 158 , which has been attributed to its ability to stimulate the growth of colorectal cancer cells 159 . This activity depends on the interactions between E-cadherin and the F. nucleatum adhesin FadA; the expression of FadA is elevated in the cancerous colon tissue and correlates with the expression of oncogenic and inflammatory genes 159 . Porphyromonas gingivalis is associated with oral squamous cell carcinoma (OSCC) 160, 161 , orodigestive cancer (independently of periodontitis) 162 and pancreatic cancer 163 . Certain immune-subversive mechanisms of P. gingivalis are consistent with a role in cancer development (see the figure) . In OSCC cells, P. gingivalis induces the expression of the pro-form of matrix metalloproteinase 9 (pro-MMP9) by triggering proteinase-activated receptor 2 (PAR2)-mediated nuclear factor-κB (NF-κB) activation (through an extracellular mechanism involving gingipain secretion) or by activating extracellular signal-regulated kinase 1 (ERK1)-ERK2 and p38 mitogen-activated protein kinase (MAPK) pathways, through an intracellular mechanism requiring β1-integrin-dependent invasion 164 . In addition, the gingipains cleave the secreted pro-enzyme into mature MMP9 (also known as gelatinase), which promotes carcinoma cell migration 164 . P. gingivalis invasion of epithelial cells suppresses apoptosis and stimulates cell proliferation by inhibiting the tumour suppressor p53 (REF. 165 ). The ability of P. gingivalis to activate the Janus kinase 1 (JAK1) and signal transducer and activator of transcription 3 (STAT3) pathway, as well as the phosphoinositide 3-kinase (PI3K) -AKT signalling pathway, causes inhibition of the intrinsic mitochondrial apoptosis pathways 149, 166 . Specifically, STAT3, which upregulates the anti-apoptotic molecules survivin and B cell lymphoma 2 (BCL-2), and AKT, which inhibits the pro-apoptotic molecule BCL-2-associated agonist of cell death (BAD), lead to caspase 3 inhibition (see the inset) 148, 149 . Moreover, extracellular release of nucleoside diphosphate kinase (NDK) by P. gingivalis cleaves ATP and prevents the induction of apoptosis via the P2X purinergic receptor 7 (P2X 7 ) Link between P. gingivalis and rheumatoid arthritis. The unique ability of P. gingivalis to citrullinate proteins has attracted considerable interest in the field of rheumatoid arthritis given the importance of ACPAs in disease pathogenesis 5, 131 . In this context, P. gingivalis was shown to citrullinate human fibrinogen and α-enolase, which, in their citrullinated forms, are two major rheumatoid arthritis autoantigens 31 . This activity requires concerted action between PPAD and arginine-specific gingipains, which colocalize with PPAD in the outer membrane of P. gingivalis 31 . Specifically, the cleavage of fibrinogen or α-enolase by gingipains exposes C-terminal arginine residues that are subsequently citrullinated by PPAD 31 . In principle, the unique mode of proteolytic processing and post-translational modification of host antigens by P. gingivalis could generate neoepitopes to which immune tolerance does not exist, which would lead to the generation of autoantibodies (FIG. 5) . It should be noted that the breakdown of immune tolerance to citrullinated proteins requires susceptible individuals, such as carriers of HLA-DRB1 shared epitope alleles that bind selectively to citrullinated sequences and may influence antigen presentation in ways that lead to ACPA production 134 . Intriguingly, rheumatoid arthritis-specific autoantibodies to citrullinated α-enolase peptide 1 (the immunodominant B cell epitope of human α-enolase) were shown to cross-react with citrullinated enolase from P. gingivalis, suggesting that molecular mimicry can contribute to autoantibody generation 135 . A 'two-hit' model of rheumatoid arthritis pathogenesis was proposed involving the initial breakdown of tolerance to citrullinated peptides generated by P. gingivalis in inflamed gingiva, followed by epitope spreading to other host-citrullinated proteins in the inflamed joint 5, 31 (FIG. 5) .
In this regard, citrullinated proteins have been detected in the gingiva of patients with periodontitis 5 . Moreover, the notion that immunity to citrullinated proteins is initially triggered in inflamed mucosal surfaces that are distant from the joints is consistent with the presence of ACPAs before signs of inflammation in the joints 136 . Mechanisms of epitope spreading or molecular mimicry could lead to cross-reactivity with citrullinated joint proteins and the subsequent formation of immune complexes that could exacerbate or perpetuate the inflammatory process in Nature Reviews | Immunology rheumatoid arthritis through several mechanisms, including activation of complement or Fc receptors for IgG (Fcγ receptors) 5, 31 (FIG. 5) . Epitope spreading precedes the development of rheumatoid arthritis and leads to the maintenance and progression of inflammation as it sustains the generation of high-affinity ACPAs to citrullinated host proteins 5, 137 .
The two-hit model is consistent with the results of two recent mechanistic studies by independent groups. Specifically, infection of mice with wild-type P. gingivalis exacerbates collagen-or collagen-antibody-induced arthritis, as shown by the accelerated progression and enhanced severity of bone and cartilage destruction 30, 138 . The ability of wild-type P. gingivalis strains to aggravate arthritis is strictly dependent on PPAD expression, as isogenic mutants lacking this enzyme fail to influence disease outcome 30, 138 . Furthermore, the infection of mice with wild-type, but not with PPAD-deficient, P. gingivalis was associated with the detection of citrullinated proteins at the site of infection, and with the production of ACPAs 30, 138 . These findings suggest that, by virtue of its PPAD, P. gingivalis may constitute a mechanistic link between periodontitis and rheumatoid arthritis.
Periodontitis and respiratory diseases Aspiration pneumonia. The tooth-associated bacterial biofilm is thought to be a reservoir for respiratory infections, and oral anaerobic bacteria are common isolates from aspiration pneumonia and lung abscesses 22, 139, 140 . Oropharyngeal aspiration of bacteria is a major cause of pneumonia in older people and immunocompromised individuals 139, 140 , and periodontitis is epidemio logically implicated as a mortality risk factor for aspiration pneumonia, at least in the elderly 141 . As patients probably aspirate fragments of the biofilm, which is composed of mixed bacterial species, the synergistic polymicrobial inter actions that are seen in periodontitis might also occur in the lung tissue. Despite limited research in this area, mixed infection with P. gingivalis and T. denticola in a mouse model of aspiration pneumonia has been shown to cause considerably increased inflammatory responses, impaired bacterial clearance and more severe lung pathology compared with single infection with either bacterium 142 . Importantly, the control of the oral microbial burden substantially decreases the incidence of aspiration pneumonia in frail elderly people 143, 144 , which suggests a direct association between oral bacteria and lung pathology in susceptible individuals. These results warrant more basic studies to investigate the mechanisms involved.
Chronic obstructive pulmonary disease. Periodontitis is also associated with chronic obstructive pulmonary disease (COPD) 23, 145 . Polymicrobial infections, including infections with the opportunistic pathogen Pseudomonas aeruginosa, are associated with exacerbations of COPD and increase its morbidity and mortality 23, 146 . P. gingivalis is readily detectable with P. aeruginosa in tracheal aspirates of patients with acute COPD exacerbations 24 , and can enhance the pathogenicity of P. aeruginosa in the context of lower airway infection 147, 148 . Indeed, P. gingivalis promotes the ability of P. aeruginosa to invade respiratory epithelial cells and modulates its apoptosisinducing capacity 147, 148 . Specifically, compared with the invasion of P. aeruginosa alone, co-invasion of the respiratory epithelial cells with both bacteria leads to diminished apoptosis as a result of the enhanced signalling of signal transducer and activator of transcription 3 (STAT3), which upregulates the expression of the anti-apoptotic molecules survivin and B cell lymphoma 2 (BCL-2), and in turn leads to the inhibition of caspase 3 (REF. 148 ). Moreover, co-invasion is followed by the downregulation of the pro-apoptotic molecule BCL-2-associated agonist of cell death (BAD) 148 , which is possibly mediated by PI3K-AKT signalling 149 (see the figure in BOX 2) . However, the inhibition of apoptosis is transient as the signalling pathways that are involved start to decline 8 hours post-invasion of both bacteria, leading to dramatically increased caspase 3 activity by 12 hours post-invasion 148 . Rapid apoptosis of infected epithelial cells is thought to contribute to the effective clearance of P. aeruginosa 150 . This suggests that the inhibition of epithelial cell apoptosis for a substantial amount of time following P. aeruginosa and P. gingivalis co-invasion may provide the bacteria with a safe intracellular niche and the opportunity to proliferate and establish infection.
Conclusions and perspective
Dysbiotic microbial communities in the periodontium resist immune elimination and create permissive conditions for growth in a nutritionally favourable inflammatory environment 11, 13, [17] [18] [19] 41, 42 (FIGS 1,2) . The immune-subversive and pro-inflammatory strategies that promote the fitness of periodontal bacteria not only cause collateral damage to the periodontium, but also have repercussions that link periodontitis to systemic afflictions . The virulence of individual periodontal pathogens is maximized in the context of a poly microbial infection 17, 19, [47] [48] [49] [50] [51] 53 , and its impact on the host depends on genetic predisposition and environmental modifiers 92, [151] [152] [153] [154] [155] 
. Hence, to better understand the mechanisms of the pathogenesis of periodontitis and associated systemic conditions, data from epidemiological and animal model studies need to be integrated with those from metatranscriptomic and metaproteomic approaches, as well as with data from whole-genome transcriptomic and proteomic analyses of tissue samples from healthy individuals and from patients with different stages of disease. This integration can offer insights into the dynamic nature of host-microorganism interactions in disease development and, moreover, can facilitate the formulation of novel hypotheses for further studies. More importantly, key findings from basic research need to be translated into clinical applications and inform the development of therapies that counteract the immune-subversive mechanisms of periodontal bacteria, thereby contributing to the treatment of periodontitis and associated systemic inflammatory disorders. Such host-modulation strategies are more likely to succeed than direct antimicrobial approaches, particularly when targeting keystone pathogens, which can act at low abundance and will probably not be completely eradicated, partly because they can hide within permissive host cells.
